The Clinical Practice Research Datalink (CPRD), an anonymized longitudinal medical records database, is being launched to provide the UK life-sciences industry with a "world-class" health service that may well revolutionize the way clinical trials are conducted, the Medicines and Healthcare products Regulatory Agency (MHRA) said in a statement.
The MHRA-managed CPRD "will help researchers to better understand the causes of illness and protect public health while ensuring that the UK is the place for new health research projects," said MHRA in a statement.
CPRD will also "provide novel and powerful ways in which clinical trials can be undertaken," according to MHRA.
The CPRD, launched 29 March 2012, is composed of the General Practice Research Database (GPRD) and the National Institute for Health Research's (NIHR) Research Capability Programme.
"The CPRD is not so much about creating a new reservoir of data as establishing productive relationships between previously siloed datasets in primary, secondary and tertiary care, as well as streamlining the processes through which researchers can access those data," explains Pharma Times.
According to MHRA, the CPRD will include:
Read more:
MHRA - Clinical Practice Research Datalink launches to improve health research
PharmaTimes - Clinical Practice Research Datalink launched in the UK